Artificial Intelligence
Type 1 Diabetes Market Size is Projected to Reach USD 2,800 Million by 2026, Globally: Facts & Factors
New York, NY, March 01, 2021 (GLOBE NEWSWIRE) — Facts and Factors have published a new research report titled “Type 1 Diabetes Market By Insulin Analog (Rapid-Acting Insulin Analogs, Long-Acting Insulin Analogs, and Premix Insulin Analogs): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026”.
“According to the research study, the global Type 1 Diabetes Market was estimated at USD 2,000 Million in 2019 and is expected to reach USD 2,800 Million by 2026. The global Type 1 Diabetes Market is expected to grow at a compound annual growth rate (CAGR) of 5% from 2019 to 2026”.
Type 1 diabetes is a type of diabetes where an autoimmune response towards insulin-making beta cells of the pancreas leads to the early destruction of the pancreas. Type 1 diabetes mellitus is idiopathic but has a strong association with genes such as HLA-DR4 and HLA-DR3. Type 1 diabetes symptoms are increase thrust, extreme weight loss stomach upset, increase frequency of urination, fatigue, delayed healing, etc. One of the key remedies against type 1 diabetes is insulin therapy. Parents and the child should have proper knowledge of the condition. The primary goal in the case of type 1 diabetes is to keep the insulin level as close to normal. The treatment prescribed to the patient involves monitoring the blood sugar level within limit via diet, exercise, and insulin therapy. If left untreated, the type 1 diabetic patient experiences loss of consciousness. Uncontrolled diet and insulin may cause high blood sugar (hyperglycemia), increased ketones in urine, hypoglycemia, etc.
Request Your Free Sample Report of Type 1 Diabetes Market @ https://www.fnfresearch.com/sample/type-1-diabetes-market-by-insulin-analog-rapid-1256
(The free sample of this report is readily available on request).
Our Free Sample Report Includes:
- 2020 Updated Report Introduction, Overview, and In-depth industry analysis
- COVID-19 Pandemic Outbreak Impact Analysis Included
- 190+ Pages Research Report (Inclusion of Updated Research)
- Provide Chapter-wise guidance on Request
- 2020 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
- Includes Updated List of table & figures
- Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
- Facts and Factors research methodology
(Note: The sample of this report is updated with COVID-19 impact analysis before delivery)
Key Questions Answered in this Report
1) What was the impact of COVID-19 on the Type 1 Diabetes Market?
2) What is the market size, share of the Type 1 Diabetes Market?
3) Who are the top market players in the Type 1 Diabetes Market?
4) What will be the future market of Type 1 Diabetes Market?
Key Offerings:
- Market Size & Forecast by Revenue | 2020−2026
- Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
- Market Segmentation – A detailed analysis by product, by types, end-user, applications, segments, and geography
- Competitive Landscape – Top key vendors and other prominent vendors
Inquire more about this report before purchase @ https://www.fnfresearch.com/inquiry/type-1-diabetes-market-by-insulin-analog-rapid-1256
(You may enquire a report quote OR available discount offers to our sales team before purchase.)
Impact Analysis of COVID-19 Pandemic on Businesses: Know Short Term and Long Term Impact
Most of the businesses are facing a growing litany of business-critical concerns related to the coronavirus outbreak, including supply chain disruptions, a risk of a recession, and a potential drop in consumer spending. All these scenarios will play out differently across various regions and industries, making accurate and timely market research more essential than ever.
We at Facts and Factors (http://www.fnfresearch.com) understand how difficult it is for you to plan, strategize, or make business decisions, and as such, we have your back to support you in these uncertain times with our research insights. Our team of consultants, analysts, and experts has developed an analytical model tool for markets that helps us to assess the impact of the virus more effectively on the industrial markets. We are further implementing these insights into our reports for a better understanding of our clients.
Request COVID-19 Impact Analysis on Businesses: https://www.fnfresearch.com/sample/type-1-diabetes-market-by-insulin-analog-rapid-1256
In the last few years, there has been a steady rise in type one diabetes in children. Changing lifestyles in urban and rural parts of the world have led to the high exposure of pollution and unhealthy diet patterns among children, which has led to an increase in the number of children affected with type 1 diabetes. Type 1 diabetic patients have to rely solely on external insulin supply. These patients have to carry insulin pens for medication. Owing to such primary dependency of patients insulin has driven the global injectable insulin market. With the advancements of biomedical technology, the emergence of genetic consulting is anticipated to create new types of treatments for type 1 diabetes. Also, the Food and Drug Administration approved the first-ever artificial pancreas for type 1 diabetic patients aging 14 and old. Such technological advancements are likely to create new avenues for the global type 1 diabetic market. However, lack of awareness among patients regarding types of treatment available has hampered the market for injectable insulin for type 1 diabetes.
Top Market Players:
- Eli Lilly and Company
- Bayer Pharmaceuticals
- Sanofi
- Novo Nordisk
- AstraZeneca PLC.
- XOMA Corp.
- DiaVacs Inc.
- B.BraunMelsungen AG
- Biodel Inc.
- Macrogenics Inc.
- Takeda Pharmaceutical
To know an additional revised 2020 list of market players, request a sample report: https://www.fnfresearch.com/sample/type-1-diabetes-market-by-insulin-analog-rapid-1256
Based on insulin analog, the rapid-acting insulin analogs segment dominated the global type 1 diabetes market, accounting for a market share of 40% in 2019. A rapid-acting insulin is taken 15 minutes before a meal. Rapid-acting insulin has an onset and peak of nearly 15 minutes and 30 to 90 minutes respectively. Rapid-acting insulin offers a key advantage as it controls postprandial glucose.
The report study further includes an in-depth analysis of industry players’ market shares and provides an overview of leading players’ market position in the type 1 diabetes sector. Key strategic developments in the type 1 diabetes market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the type 1 diabetes market are appropriately highlighted in the report.
The type 1 diabetes market research report delivers an acute valuation and taxonomy of the type 1 diabetes industry by practically splitting the market on the basis of different types, categories, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026.
Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/type-1-diabetes-market-by-insulin-analog-rapid-1256
Diabetes is a defect in metabolism in the pancreas which results in hyperglycemia. Type 1 diabetes also known as insulin-dependent diabetes mellitus or juvenile diabetes is a condition where there is an immune response against insulin-producing beta cells of the pancreas. In type 1 diabetes, there has to be an external supply of insulin hence called insulin-dependent diabetes mellitus. The most severe form of diabetes leads to the early destruction of organs. A person can prevent type 2 diabetes by avoiding sugar enrich food products in the diet, however, such prevention is not possible when it comes to type 1 diabetes. The immune system strikes colonies of cells in the body that would normally generate insulin, called islets, blocking or slowing down insulin supply.
In recent years, there has been a steady rise in the number of type 1 diabetic patients. Type 1 diabetes is treated with injectable insulin and this type of insulin can’t be treated with oral supplements. Injectable insulin uses an insulin pen to inject insulin under the skin. Type 1 diabetic patients have to mainly rely on injectable insulin. Such dependency on patients has driven the global type 1 diabetes insulin market.
Request Customized Copy of Report @ https://www.fnfresearch.com/customization/type-1-diabetes-market-by-insulin-analog-rapid-1256
(We customize your report according to your research need. Ask our sales team for report customization.)
The type 1 diabetes market is segmented based on drug type and region. On the basis of insulin analogs, the market is classified into rapid-acting insulin analogs, long-acting insulin analogs, and premix insulin analogs.
Based on geography, the North America segment dominated the global type 1 diabetes market in 2019. The North America region held a major share of nearly 35% in the global type 1 diabetes market in 2019. The growth in the region is attributable to rising consumer spending on healthcare and advancements in healthcare technology. Further, the increase in the number of type 1 diabetic patients has also contributed to driving the North America type 1 diabetes market.
Browse the full “Type 1 Diabetes Market By Insulin Analog (Rapid-Acting Insulin Analogs, Long-Acting Insulin Analogs, and Premix Insulin Analogs): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” report at https://www.fnfresearch.com/type-1-diabetes-market-by-insulin-analog-rapid-1256
This report segments the type 1 diabetes market as follows:
Global Type 1 Diabetes Market: By Insulin Analog Segmentation Analysis
- Rapid-Acting Insulin Analogs
- Long-Acting Insulin Analogs
- Premix Insulin Analogs
Key Insights from Primary Research
- Our primary respondents predict that the global type 1 diabetes market is expected to grow at a CAGR of nearly 5% over the projected period.
- The rising number of type 1 diabetes patients around the world has driven the consumption of insulin, which has driven the type 1 diabetes market.
- Our primary respondents also estimate that the global type 1 diabetes market in 2026 is expected to reach a market value of nearly USD 2,800 million.
- Asia Pacific market is anticipated to grow at the fastest rate over the projected period owing to the increasing population and rising number of type 1 diabetic patients.
- Emerging technologies in healthcare have led to the development of artificial pancreas is likely to create favorable conditions for new types of diabetic treatments.
Related Reports:
Antibody Drug Conjugates Market: https://www.fnfresearch.com/antibody-drug-conjugates-market-by-drugs-adcetris-and
Protein Ingredient Market: https://www.fnfresearch.com/protein-ingredient-market-by-product-type-plant-protein-1232
Orthopedic Trauma Devices Market: https://www.fnfresearch.com/global-orthopedic-trauma-devices-market-by-product-type-1220
Intravenous Iron Drugs Market: https://www.fnfresearch.com/intravenous-iron-drugs-market-by-product-iron-dextran-1201
Drug Delivery in Cancer Market: https://www.fnfresearch.com/drug-delivery-in-cancer-market-by-product-liposomes-1157
About Facts & Factors (FnF Research):
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Follow Us LinkedIn: https://www.linkedin.com/company/fnfresearch
Follow Us Twitter: https://twitter.com/fnfresearch
Contact Us:
Facts & Factors
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
Blog: http://fnfnewsblog.com
Artificial Intelligence
Timekettle Announces Major Software Update, Launching AI Translation Lab
SHENZHEN, China, April 18, 2024 /PRNewswire/ — Timekettle, a fast-growing cross-language communication solutions innovator, has announced a significant software update with the launch of the AI Translation Lab, which will serve as a new platform to rapidly introduce cutting-edge technological features while gathering immediate user feedback to avoid releasing underdeveloped functionalities.
The AI Translation Lab represents a major advancement in rendering digital communication more personal, accurate, and educational across various languages. It introduces a range of key features aimed at greatly enhancing the accuracy and fluidity of translations.
Understanding the importance of accurate translations for proper nouns and specialized terms in everyday conversations, the AI Translation Lab features the Custom Lexicon, which allows users to create their own terms linked to specific translations, ensuring precision every time. As users add more terms over time, they will notice increasingly accurate translations with these personalized glossaries.
In an effort to counteract the mechanical feel of conventional translation tools, the AI Translation Lab has enhanced its voice feature to incorporate options that emulate human-like tonality with subtle emotional nuances. Users now have the liberty to select between male and female voices, ensuring a more organic auditory experience without sacrificing efficiency.
Customized for individuals grappling with practical language obstacles such as immigrants or international business personnel, the AI Language Tutor harnesses sophisticated AI technology to facilitate interactive learning experiences, with a focus on enhancing fluency and pronunciation. By integrating the AI Language Tutor into their ecosystem, Timekettle is not merely dismantling communication barriers, but also equipping users with the requisite skills for real-world interactions.
At present, Timekettle’s AI Translation Lab supports Chinese, English, and Spanish languages. As part of its ongoing commitment to making the world more interconnected, Timekettle is dedicated to adding more languages in upcoming updates, aligning with its goal of creating a world where people can easily communicate in their native language.
In today’s globalized world, the technologies and devices provided by Timekettle are becoming essential not just for travelers but also for international businesses that need clear communication without the setbacks of delays or errors due to poor translations. The creation of the AI Translation Lab highlights Timekettle’s dedication to developing technologies that respond to what users actually want.
Opening a door for users to evolve from simply using the technologies and devices to actively contributing to shaping our future, Timekettle invites global users to explore its AI Translation Lab, discover the latest offerings, share feedback instantly, and join the brand in breaking down language barriers through innovative technology.
About Timekettle
Established in 2016, Timekettle is an industry-leading and award-winning provider of cross-language communication solutions. Headquartered in Shenzhen, China, Timekettle also operates a customer center in Los Angeles, United States. Its exceptional products have been recognized with numerous international accolades, including the CES Innovation Award, iF Design Award, and Japan Good Design Award.
For further information, please visit https://www.timekettle.co/
Photo – https://mma.prnewswire.com/media/2390773/Al_Translation_Lab.jpg
View original content:https://www.prnewswire.co.uk/news-releases/timekettle-announces-major-software-update-launching-ai-translation-lab-302120663.html
Artificial Intelligence
Clearwater Analytics Wins IFRS 9 Solution Provider of the Year for Second Consecutive Year
Insurance Asset Risk Awards Celebrate Clearwater’s Excellence in IFRS 9 Solutions
BOISE, Idaho, April 18, 2024 /PRNewswire/ — Clearwater Analytics (NYSE: CWAN), a leading provider of SaaS-based investment management, accounting, reporting, and analytics solutions, today announced that it has won the IFRS 9 Solution Provider of the Year award for the second consecutive year. This achievement underscores Clearwater’s expertise in navigating the complexities of financial reporting and simplifying meticulous processes for our clients.
The Insurance Asset Risk Awards annually recognize outstanding technology firms in the insurance asset management sector. Clearwater Analytics distinguished itself from the competition with its cloud-based SaaS platform and dedicated Client Services offering, which provides a robust foundation to assist clients with their IFRS 9 plan, or global equivalents such as PSAK 71. The solution itself simplifies and streamlines adherence to the financial reporting rules for businesses of all sizes.
“We’re truly honored by this award, which highlights our team’s deep understanding of IFRS 9 and our dedication to supporting our clients,” said Keith Viverito, Managing Director, EMEA and APAC at Clearwater Analytics. “The journey towards IFRS 9 proficiency has been difficult for many in the industry. While insurers have become more adept over the years, there remains a significant need for improvement in operational models to align with best practices today. Clearwater simplifies the financial reporting process, making it faster and more accurate in aligning with IFRS 9 requirements. Our ability to automate the Expected Credit Loss (ECL) allowances and provide comprehensive data management solutions is a testament to our investments in innovation and relentless focus on customer success.”
One of the main challenges facing businesses for IFRS 9 adherence is the impairment of financial instruments, particularly the ECL model. Firms continuously struggle with data availability and quality, estimation techniques, scenario analysis, documentation, auditability, and the ongoing monitoring and reassessment of financial instruments. Clearwater’s success in delivering sophisticated solutions that address these challenges head-on has been a major factor behind its industry-leading 60+ NPS score.
This award joins a growing list of industry accolades, including the InsuranceAsia News Excellence Award for Technology Provider of the Year, the Chartis RiskTech Buyside 50 spot for Investment Lifecycle – Insurance/ Pension Funds, and the Captive Review Award for Software Solution of the Year. Each honor reaffirms Clearwater’s commitment to enhancing data quality and operational efficiency for clients around the globe.
Talk to an expert today to learn more about how Clearwater Analytics elevates financial operations and IFRS 9 compliance strategy.
About Clearwater Analytics
Clearwater Analytics (NYSE: CWAN), a global, industry-leading SaaS solution, automates the entire investment lifecycle. With a single instance, multi-tenant architecture, Clearwater offers award-winning investment portfolio planning, performance reporting, data aggregation, reconciliation, accounting, compliance, risk, and order management. Each day, leading insurers, asset managers, corporations, and governments use Clearwater’s trusted data to drive efficient, scalable investing on more than $7.3 trillion in assets spanning traditional and alternative asset types. Additional information about Clearwater can be found at clearwateranalytics.com.
Logo – https://mma.prnewswire.com/media/1502063/Clearwater_Analytics_v3_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/clearwater-analytics-wins-ifrs-9-solution-provider-of-the-year-for-second-consecutive-year-302120164.html
Artificial Intelligence
Buyers Edge Platform Accelerates European Expansion with Two Strategic UK Acquisitions
WALTHAM, Mass., April 18, 2024 /PRNewswire/ — Buyers Edge Platform, the leading software and analytics company providing data-driven insights and technology to the foodservice industry, announces its acquisitions of The Full Range and Delta Procurement, two prominent UK Group Purchasing Organizations (GPOs). These acquisitions mark a significant step in Buyers Edge Platform’s rapid expansion across Europe, solidifying its position as a key player in the international procurement landscape. This announcement comes on the heels of Buyers Edge Platform recently securing a $425 million Preferred Equity investment from three prominent investors: General Atlantic, Blackstone, and Morgan Stanley.
These acquisitions align with Buyers Edge Platform’s broader strategy to create the largest Digital Procurement Network in Europe, mirroring their success achieved in the US. Through strategic acquisitions, new country partnerships, and organic growth initiatives, Buyers Edge Platform is set to transform procurement, offering exceptional value to foodservice businesses across Europe.
John Davie, CEO of Buyers Edge Platform, expressed his excitement about both acquisitions, stating, “We’re seeking the best and most powerful GPOs in each country in Europe and have been looking to bring both brands on board as we continue our mission to revolutionize procurement practices and empower businesses across the continent.”
Daniel Wilson, President of Buyers Edge Platform Europe, added “We are delighted to welcome the Full Range and Delta Procurement to the Buyers Edge Platform Family. We have hugely ambitious plans to expand our operations across Europe and look forward to working with the team members, supply partners, and customers of the acquisitions to achieve this.” Buyers Edge Platform has now completed 3 European acquisitions since January 2023.
The Full Range
Founded by Co-Owners and Directors Barry Knight and Nicky Prentice, The Full Range stands as one of the largest independent GPOs in the UK. Renowned for its comprehensive support and consultancy services, The Full Range caters to diverse sectors including hotels, bars, restaurants, and golf clubs. Their sterling reputation stems from a commitment to enhancing client purchasing efficiency while fostering strong supplier relationships.
Barry Knight, Director of The Full Range, expressed his enthusiasm about the acquisition, saying: “From the very first conversation with Buyers Edge Platform, it was clear we shared the same vision and values. We are both people-focused businesses who always put the customer first. Combining our UK market knowledge with Buyers Edge Platform technology and buying power will create the perfect environment to help our customers to thrive. We are excited to have joined the most powerful network in the foodservice industry and to share the opportunities this brings to hospitality owners across the UK.”
Delta Procurement
Delta Procurement, led by Dave Anderson and Nick Ryan, has emerged as a transformative force in the UK procurement service industry. With a focus on delivering absolute value at every link of the foodservice chain, Delta has earned acclaim for its tailored solutions and exceptional customer satisfaction. The company’s success underscores its commitment to innovation and customer-centricity.
“We have always put our clients front and center of all that we do and so are thrilled about the acquisition by Buyers Edge Platform as it represents a significant opportunity for our customers. By joining forces, we can now offer our clients access to cutting-edge technology and enhanced buying power, enabling them to streamline their procurement processes and drive greater efficiencies in their businesses. This acquisition marks a new chapter for Delta and our customers, and we are excited to continue delivering exceptional value and service as part of the Buyers Edge Platform.”
For other companies who are interested in leveraging the power of Buyers Edge Platform for their customers, visit BuyersEdgePlatform.com/About/Acquisitions.
About Buyers Edge Platform
Buyers Edge Platform is the leading software and analytics company providing data-driven insights and technology to the foodservice industry. We connect entities throughout foodservice and empower them to run their businesses more efficiently by leveraging data and analytics. Buyers Edge Platform’s mission is to drive the foodservice industry from manual to automated with programs that benefit all stakeholders across the supply chain. Visit BuyersEdgePlatform.com to learn more.
Buyers Edge Platform recently announced a $425M preferred equity investment from a consortium led by General Atlantic Credit’s (“GA Credit”) Atlantic Park fund, alongside funds managed by Blackstone Tactical Opportunities (“Blackstone”) and investment funds managed by Morgan Stanley Tactical Value (“MS Tactical Value”). Buyers Edge Platform intends to leverage the new funds and partnership with GA Credit, Blackstone, and MS Tactical Value to support the execution of its continued growth initiatives, including platform innovation, strategic M&A, and European expansion.
Media contact:Ryan Gerding for Buyers Edge [email protected]
Logo – https://mma.prnewswire.com/media/2389990/BEP_Logo_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/buyers-edge-platform-accelerates-european-expansion-with-two-strategic-uk-acquisitions-302119974.html
-
Artificial Intelligence6 days ago
In-Depth Analysis of Germany and France Data Center Markets: Germany Poised to Contribute Over $12.24 Billion Opportunities in the Next 6 Years – Arizton
-
Uncategorized6 days ago
Arm CEO Rene Haas will be delivering a Partner’s Event Speech at COMPUTEX 2024
-
Uncategorized6 days ago
BJEI: A New Record of High Performance in 2023 and a New Pattern of Diversified and Coordinated Development
-
Uncategorized6 days ago
Dimethyl Carbonate Market worth $1.9 billion by 2028 – Exclusive Report by MarketsandMarkets™
-
Uncategorized6 days ago
Integrity Food Marketing Joins Forces with CA Ferolie to Expand East Coast Reach from Maine to Florida
-
Artificial Intelligence6 days ago
CogX Festival Set to Debut in Los Angeles at Century Plaza on May 7th, 2024
-
Artificial Intelligence6 days ago
aelf Leads the Fusion of AI and Blockchain to Shape the Future of Technology
-
Artificial Intelligence6 days ago
Xinhua Silk Road: Zoomlion Access pursues high-quality development with aerial work machinery sector innovation